Mark J. Gergen, SVP, Corporate Development at AMYLIN PHARMACEUTICALS INC (AMLN), sold 1,846 shares at $17.11 ($32K) on 2012-03-01, disclosed to the SEC on 2012-03-02.
Open-market sale of $32k AMLN by SVP, Corporate Development. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| MRTX | SELL | 2016-01-19 | $518K | — | Filing → |
| AMLN | SELL | 2012-02-24 | $128K | — | Filing → |
| AMLN | SELL | 2007-11-02 | $22K | — | Filing → |